Genetic Diseases, X-Linked

Subtype terms (25)

More specific conditions that are subtypes of Genetic Diseases, X-Linked in the MeSH hierarchy.

• Aicardi Syndrome

  5 drugs approved

• Androgen-Insensitivity Syndrome
• Barth Syndrome

  2 drugs approved

• Bulbo-Spinal Atrophy, X-Linked

  8 drugs (4 approved, 4 experimental)

• Choroideremia

  9 drugs (2 approved, 7 experimental)

• Dent Disease

  2 drugs approved

• Dyskeratosis Congenita

  21 drugs (17 approved, 4 experimental)

• Ectodermal Dysplasia 1, Anhidrotic

  2 drugs (1 approved, 1 experimental)

• Fabry Disease

  30 drugs (16 approved, 14 experimental)

• Focal Dermal Hypoplasia
• Glycogen Storage Disease Type IIb

  1 drug experimental

• Glycogen Storage Disease Type VIII
• Granulomatous Disease, Chronic

  52 drugs (30 approved, 22 experimental)

• Hemophilia B

  54 drugs (23 approved, 31 experimental)

• Hyper-IgM Immunodeficiency Syndrome, Type 1

  9 drugs approved

• Ichthyosis, X-Linked
• Isolated Noncompaction of the Ventricular Myocardium
• Muscular Dystrophy, Duchenne

  113 drugs (46 approved, 67 experimental)

• Muscular Dystrophy, Emery-Dreifuss
• Oculocerebrorenal Syndrome
• Ornithine Carbamoyltransferase Deficiency Disease

  11 drugs (3 approved, 8 experimental)

• Pelizaeus-Merzbacher Disease

  4 drugs (1 approved, 3 experimental)

• Wiskott-Aldrich Syndrome

  34 drugs (26 approved, 8 experimental)

• X-Linked Combined Immunodeficiency Diseases

  23 drugs (12 approved, 11 experimental)

• X-Linked Intellectual Disability

  1 drug approved

Drugs by status

Organizations